Vasoactive mediators and retinopathy during type 1 diabetic pregnancy

Acta Ophthalmologica Scandinavica

Volumn 83, Issue 1, 2005, Pages 57-62

  Loukovaara, Sirpa ^a   Immonen, Ilkka J ^a   Yandle, Tim G ^b   Nicholls, Gary ^b   Hiilesmaa, Vilho K ^a   Kaaja, Risto J ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Diabetic pregnancy; Diabetic retinopathy; Natriuretic peptides; Renin angiotensin system; Vasoactive hormones

Indexed keywords

ADREONOMEDULLIN; ALDOSTERONE; ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; BIOCHEMICAL MARKER; BRAIN NATRIURETIC PEPTIDE; GLYCOSYLATED HEMOGLOBIN; NATRIURETIC FACTOR; NATRIURETIC PEPTIDE TYPE C; RENIN; UNCLASSIFIED DRUG; VASOACTIVE AGENT;

ADULT; ARTICLE; BLOOD FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; EYE FUNDUS; EYE PHOTOGRAPHY; FEMALE; FIRST TRIMESTER PREGNANCY; HEMODYNAMICS; HEMOGLOBIN DETERMINATION; HORMONE BLOOD LEVEL; HORMONE RESPONSE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PLASMA RENIN ACTIVITY; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUERPERIUM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; THIRD TRIMESTER PREGNANCY;

ADRENOMEDULLIN; ADULT; ALDOSTERONE; ANGIOTENSIN II; BLOOD FLOW VELOCITY; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; DISEASE PROGRESSION; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; NATRIURETIC PEPTIDES; PEPTIDES; PREGNANCY; PREGNANCY IN DIABETICS; RENIN; RENIN-ANGIOTENSIN SYSTEM; RETINAL VESSELS; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 14744274307     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2005.00384.x     Document Type: Article

References (39)

1. Atkins AFJ, Wat JM, Milan P, Davies P & Crawford JS (1981): A longitudinal study of cardiovascular dynamic changes throughout pregnancy. Eur J Obstet Gynecol Reprod Biol 12: 215-224.
2. Bojestig M, Nystrom FH, Arnqvist HJ, Ludvigsson J & Karlberg BE (2000): The renin-angiotensin-aldosterone system is suppressed in adults with type 1 diabetes. J Renin Angiotensin Aldosterone Syst 1 353-356.
3. Castro LC, Hobel CJ & Gornbein J (1994): Obstetrics: plasma levels of atrial natriuretic peptide in normal and hypertensive pregnancies: a meta-analysis. Am J Obstet Gynecol 171: 1642-1651.
4. Christlieb AR, Janka HU, Kraus B et al. (1976): Vascular reactivity to angiotensin II and to norepinephrine in diabetic subjects. Diabetes 25: 268-274.
5. Danser AH, Derkx FH, Admiraal PJ, Deinum J, de Jong PT & Schalekamp MA (1994): Angiotensin levels in the eye. Invest Ophthalmol Vis Sci 35: 1008-1018.
6. Diabetes Control and Complications Trial (DCCT) Research Group (1993): The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986.
7. Di Iorio R, Marinoni E, Urban G, Costantini A, Cosmi EV & Letizia C (2001): Fetomaternal adrenomedullin levels in diabetic pregnancy. Horm Metab Res 33: 486-490.
8. Drury PL, Smith GM, Ferriss JB (1984): Increased vasopressor responsiveness to angiotensin II in type I (insulin-dependent) diabetic patients without complications. Diabetologia 27: 174-179.
9. Dunn PJ & Espiner EA (1976): Outpatient screening tests for primary aldosteronism. Aust N Z J Med 6: 131-135.
10. Dussaule JC, Grimaldi A, Czekalski S, Coutarel P, Bosquet F & Ardaillou R (1988): Atrial natriuretic peptide in diabetic patients with microangiopathy. Horm Metab Res 20: 592-594.
11. Early Treatment Diabetic Retinopathy Study Research Group (1991): Grading diabetic retinopathy from stereoscopic colour fundus photographs: an extension of the modified Airlie House classification. EDTRS Report No. 10. Ophthalmology 98: 786-806.
12. Hellstedt T, Kaaja R, Teramo K & Immonen I (1996): Macular blood flow during pregnancy in patients with early diabetic retinopathy measured by blue-field entoptic simulation. Graefes Arch Clin Exp Ophthalmol 234: 659-663.
13. Hunt PJ, Richards AM, Espiner EA, Nicholls MG & Yandle TG (1994): Bioactivity and metabolism of C-type natriuretic peptide in normal man. J Clin Endocrinol 78: 1428-1435.
14. Immonen I, Siimes A, Stenman U-H, Kärkkäinen J & Fyhrqvist F (1983): Plasma renin substrate and oestrogens in normal pregnancy. Scand J Clin Invest 43: 61-65.
15. Kaaja R, Sjöberg L, Hellstedt T, Immonen I, Sane T & Teramo K (1996): Longterm effects of pregnancy on diabetic complications. Diabetic Med 13: 165-169.
16. Laatikainen L, Teramo K, Hieta-Heikurainen H, Koivisto V & Pelkonen R (1987): A controlled study of the influence of continuous subcutaneous insulin infusion treatment on diabetic retinopathy during pregnancy. Acta Med Scand 221: 367-376.
17. Lainchbury JG, Cooper GJ, Coy DH, Jiang NY, Lewis LK, Yandle TG, Richards AM & Nicholls MG (1997): Adrenomedullin: a hypotensive hormone in man. Clin Sci 92: 467-472.
18. Lauszus F, Klebe JG & Bek T (2000): Diabetic retinopathy in pregnancy during tight metabolic control. Acta Obstet Gynecol Scand 79 367-370.
19. Lewis LK, Smith MW, Yandle TG, Richards AM & Nicholls MG (1998): The measurement of adrenomedullin (1-52) in human plasma by radioimmunoassay: plasma levels, absorption and storage. Clin Chem 44 571-577.
20. Loukovaara S, Harju M, Kaaja R & Immonen I (2003): Retinal capillary blood flow in diabetic and non-diabetic women during pregnancy and postpartum period. Invest Ophthalmol Vis Sci 44: 1486-1491.
21. Lun S, Espiner EA, Nicholls MG & Yandle TG (1983): A direct radioimmunoassay for aldosterone in plasma. Clin Chem 29: 268-271.
22. McCance DR, McKnight JA, Traub AI, Sheridan B, Roberts C & Atkinson AB (1990): Plasma atrial natriuretic factor levels during normal pregnancy and pregnancy complicated by diabetes mellitus and hypertension. J Human Hypertens 4: 31-35.
23. Minegishi T, Nakamura M, Abe K et al. (1999): Adrenomedullin and atrial natriuretic peptide concentrations in normal pregnancy and pre-eclampsia. Mol Hum Reprod 5: 767-770.
24. Nicholls MG & Espiner EA (1976): A sensitive, rapid radioimmunoassay for angiotensin II. N Z Med J 83: 399-403.
25. Opocher G, Mantero F, Rocco S et al. (1989): Atrial natriuretic factor in hypertensive and normotensive insulin-dependent diabetics. J Hypertens 7 (Suppl): 236-237.
26. Pio R, Martinez A & Cuttita F (2001): Cancer and diabetes: two pathological conditions in which adrenomedullin may be involved. Peptides 22: 1719-1729.
27. Sala C, Campise M, Ambroso G, Motta T, Zanchetti A & Morganti A (1995): Atrial natriuretic peptide and haemodynamic changes during normal human pregnancy. Hypertension 25: 631-636.
28. Soubrane G, Canivet J & Coscas G (1985): Influence of pregnancy on the evolution of background retinopathy: preliminary results of a prospective fluorescein angiography study. Int Ophthalmol Clin 8 249-255.
29. Stepan H, Walther T, Walther D & Faber R (1998): Detection of C-type natriuretic peptide in normal pregnancy. J Perinat Med 26: 56-58.
30. Strain WD & Chaturvedi N (2002): The renin-angiotensin-aldosterone system and the eye in diabetes. J Renin Angiotensin Aldosterone Syst 3: 243-246.
31. Thomas W, Shen Y, Molitch ME & Steffes MW (2001): Rise in albuminuria and blood pressure in patients who progressed to diabetic nephropathy in the Diabetes Control and Complications Trial. J Am Soc Nephrol 12: 333-340.
32. Turk HM, Buyukberber S, Sevinc A, Ak G, Ates M, Sari R, Savli H & Cigli A (2000): Relationship between plasma adrenomedullin levels and metabolic control, risk factors and diabetic microangiopathy in patients with type 2 diabetes. Diabetes Care 23: 864-867.
33. Wagner J, Jan Danser AH, Derkx FH, de Jong TV, Paul M, Mullins JJ, Schalekamp MA & Ganten D (1996): Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in human eye: evidence for an intraocular renin-angiotensin system. Br J Ophthalmol 80: 159-163.
34. Wilkinson-Berka JL, Kelly DJ & Gilbert RE (2001): The interaction between the renin-angiotensin system and vascular endothelial growth factor in the pathogenesis of retinal neovascularization in diabetes. J Vasc Res 38: 527-535.
35. Williams B (1998): Angiotensin II, VEGF and diabetic retinopathy. Lancet 351: 837-838.
36. Yandle TG, Espiner EA, Nicholls MG & Duff H (1986): Radioimmunoassay and characterization of atrial natriuretic peptide in human plasma. J Clin Endocrinol Metab 63: 72-79.
37. Yandle TG, Richards AM, Gilbert A, Fisher S, Holmes S & Espiner EA (1993): Assay for brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure. J Clin Endocrinol Metab 76: 832-838.
38. Yano Y, Ura H, Gabazza EC, Seguchi C, Sumida Y, Misaki M & Shima T (1998): Circulating levels of 7S domain of type IV collagen and atrial natriuretic peptide in normotensive type 2 diabetic patients with or without retinopathy. Horm Metab Res 30: 103-107.
39. Yoshimura T, Yoshimura M, Yasue H, Ito M, Okamura H, Mukoyama M & Nakao K (1994): Plasma concentration of atrial natriuretic peptide and brain natriuretic peptide during normal human pregnancy and the postpartum period. J Endocrinol 140: 393-397.